The number of U.S. adults with severe obesity increased from 2013 to 2023, according to a research letter published ...

Aristotle Atlantic’s Large Cap Growth Composite posted a total return of 6.29% gross of fees, underperforming the 7.07% ...

Eli Lilly wants to take big swings in Alzheimer’s, ALS, chronic pain and other difficult diseases after its success in ...

Northwell Health partnered with Stacker to examine how rising prices for healthy foods impact low-income families, using data ...

Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments ... which was recently approved in the United States as a treatment for some ...

A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

Eli Lilly and Company’s LLY shares have risen 4.3% since it reported fourth-quarter results on Feb. 6. Lilly’s fourth-quarter ...

There are no studies documenting the percentage of doctors taking the drugs. But physicians “are a good litmus test for drugs ...

Diabetes and Obesity Drugs Fuel Eli Lilly Profit in ... which was recently approved in the United States as a treatment for some forms of sleep apnea. Additional approvals like that and Lilly's ...

Prescriptions of obesity management drugs (OMDs ... The researchers found that 69,213,936 prescriptions for OMDs were ...

Evenity recorded sales of $431 million in the quarter, up 36% year over year, driven by solid volume growth in the United States. Evenity sales beat the Zacks Consensus Estimate of $413.0 million ...